Insiders Updates
An Analysis of Iterum Therapeutics Plc (ITRM)’s Potential Price Growth
Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug
Menu
Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug
Iterum Therapeutics Plc’s recently made public that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug 08
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Iterum Therapeutics Plc’s recently made public that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug 08